Pharmacometrics Golems: Exposure-Response Models in Oncology
Khandelwal, Akash, Grisic, Ana-Marija, French, Jonathan, Venkatakrishnan, Karthik
Published in Clinical pharmacology and therapeutics (01.11.2022)
Published in Clinical pharmacology and therapeutics (01.11.2022)
Get more information
Journal Article
Quantitative relationship between infliximab exposure and inhibition of C‐reactive protein synthesis to support inflammatory bowel disease management
Grisic, Ana‐Marija, Eser, Alexander, Huisinga, Wilhelm, Reinisch, Walter, Kloft, Charlotte
Published in British journal of clinical pharmacology (01.05.2021)
Published in British journal of clinical pharmacology (01.05.2021)
Get full text
Journal Article
Semimechanistic Clearance Models of Oncology Biotherapeutics and Impact of Study Design: Cetuximab as a Case Study
Grisic, Ana‐Marija, Khandelwal, Akash, Bertolino, Mauro, Huisinga, Wilhelm, Girard, Pascal, Kloft, Charlotte
Published in CPT: pharmacometrics and systems pharmacology (01.11.2020)
Published in CPT: pharmacometrics and systems pharmacology (01.11.2020)
Get full text
Journal Article
Model-Based Characterization of the Bidirectional Interaction Between Pharmacokinetics and Tumor Growth Dynamics in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
Grisic, Ana-Marija, Xiong, Wenyuan, Tanneau, Lénaïg, Jönsson, Siv, Friberg, Lena E, Karlsson, Mats O, Dai, Haiqing, Zheng, Jenny, Girard, Pascal, Khandelwal, Akash
Published in Clinical cancer research (01.04.2022)
Published in Clinical cancer research (01.04.2022)
Get full text
Journal Article
Tumor growth inhibition modeling in patients with second line biliary tract cancer and first line non‐small cell lung cancer based on bintrafusp alfa trials
Milenković‐Grišić, Ana‐Marija, Terranova, Nadia, Mould, Diane R., Vugmeyster, Yulia, Mrowiec, Thomas, Machl, Andreas, Girard, Pascal, Venkatakrishnan, Karthik, Khandelwal, Akash
Published in CPT: pharmacometrics and systems pharmacology (01.01.2024)
Published in CPT: pharmacometrics and systems pharmacology (01.01.2024)
Get full text
Journal Article
A multistate modeling and simulation framework to learn dose–response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer
Liu, Han, Milenković‐Grišić, Ana‐Marija, Krishnan, Sreenath M., Jönsson, Siv, Friberg, Lena E., Girard, Pascal, Venkatakrishnan, Karthik, Vugmeyster, Yulia, Khandelwal, Akash, Karlsson, Mats O.
Published in CPT: pharmacometrics and systems pharmacology (01.11.2023)
Published in CPT: pharmacometrics and systems pharmacology (01.11.2023)
Get full text
Journal Article
Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure
Edlund, Helena, Grisic, Ana-Marija, Steenholdt, Casper, Ainsworth, Mark A, Brynskov, Jørn, Huisinga, Wilhelm, Kloft, Charlotte
Published in Therapeutic drug monitoring (01.04.2019)
Published in Therapeutic drug monitoring (01.04.2019)
Get more information
Journal Article
Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease
Grišić, Ana‐Marija, Dorn‐Rasmussen, Maria, Ungar, Bella, Brynskov, Jørn, Ilvemark, Johan F. K. F., Bolstad, Nils, Warren, David J., Ainsworth, Mark A., Huisinga, Wilhelm, Ben‐Horin, Shomron, Kloft, Charlotte, Steenholdt, Casper
Published in United European gastroenterology journal (01.02.2021)
Published in United European gastroenterology journal (01.02.2021)
Get full text
Journal Article
Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1
Vugmeyster, Yulia, Grisic, Ana-Marija, Wilkins, Justin J., Loos, Anja H., Hallwachs, Roland, Osada, Motonobu, Venkatakrishnan, Karthik, Khandelwal, Akash
Published in Cancer chemotherapy and pharmacology (01.10.2022)
Published in Cancer chemotherapy and pharmacology (01.10.2022)
Get full text
Journal Article
44 – Infliximab Clearance is Decreased During 2Nd and 3Rd Trimesters of Pregnancy in Inflammatory Bowel Disease
Grisic, Ana-Marija, Rasmussen, Maria, Ungar, Bella, Ilvemark, Johan F., Huisinga, Wilhelm, Bolstad, Nils, Warren, David J., Ben-Horin, Shomron, Ainsworth, Mark A., Brynskov, Jorn, Kloft, Charlotte, Steenholdt, Casper
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2019)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2019)
Get full text
Journal Article
Absence of relationship between CDAI or CRP and infliximab exposure calls for objective Crohn's disease activity measures for the evaluation of treatment effects at treatment failure
Edlund, Helena, Grisic, Ana-Marija, Steenholdt, Casper, Ainsworth, Mark A, Brynskov, Jørn, Huisinga, Wilhelm, Kloft, Charlotte
Published in Therapeutic drug monitoring (26.12.2018)
Get more information
Published in Therapeutic drug monitoring (26.12.2018)
Journal Article